Greylin Investment Mangement Cut Its Gilead Sciences (GILD) Position by $8.15 Million; Stock Price Declined; As Novo Nordisk A/S (NVO) Shares Rose, Holder Sustainable Growth Advisers LP Trimmed Its Stake – The EN Herald

This post was originally published on this site

Greylin Investment Mangement Cut Its Gilead Sciences (GILD) Position by $8.15 Million; Stock Price Declined; As Novo Nordisk A/S (NVO) Shares Rose, Holder Sustainable Growth Advisers LP Trimmed Its Stake  The EN Herald

Greylin Investment Mangement Inc decreased its stake in Gilead Sciences Inc (GILD) by 91.99% based on its latest 2018Q4 regulatory filing with the SEC.

This post was originally published on *this site*